|1.||Vanitha, Kaliappan: 1 article (01/2008)|
|2.||Sriram, Dharmarajan: 1 article (01/2008)|
|3.||Neelakantan, Harshini: 1 article (01/2008)|
|4.||Yogeeswari, Perumal: 1 article (01/2008)|
|5.||Kavya, Ramkumar: 1 article (01/2008)|
|6.||Ragavendran, Jegadeesan Vaigunda: 1 article (01/2008)|
03/01/1994 - "V.GABA and P.GABA were the most effective anticonvulsant GABA derivatives in protecting all the components of MES-induced seizures. "
09/01/1989 - "ED50 of P-GABA and sodium valproate against bicuculline-induced convulsion was 96 and 301 mg/kg respectively in mice."
09/01/1989 - "A new gamma-aminobutyric acid derivative, N-phthaloyl GABA (P-GABA), was synthesised and its anticonvulsant activity was tested and compared with sodium valproate for efficacy against experimentally induced convulsions in mice. "
03/01/1994 - "Out of fourteen compounds reported here only four [N-valproyl GABA (V.GABA), N-phthaloyl GABA (P.GABA), gamma-phthalimido N-amyl butyramide (PGA) and gamma-phthalimido N-phenyl butyramide (PGP)] gave significant protection to all the four components of maximal electroshock-induced seizures (MES) in mice. "
|2.||Neuralgia (Stump Neuralgia)
|3.||Alzheimer Disease (Alzheimer's Disease)
|2.||gamma-Aminobutyric Acid (GABA)
|3.||Valproic Acid (Valproate, Semisodium)
|4.||Prostaglandins A (PGA)